DE O'Donnell, DJ Bain and KA Webb
Department of Medicine, Queen's University, Kingston, Ontario, Canada.

The mechanisms of exertional dyspnea relief in response to supplemental oxygen (O2) in chronic airflow limitation (CAL) are not precisely known and are likely multifactorial. To explore factors contributing to the relief of dyspnea after oxygen administration, 11 patients with severe CAL (FEV1.0 = 39 +/- 3% predicted, mean +/- SEM) and mild hypoxemia (resting PaO2 = 74 +/- 2 mm Hg) breathed room air (RA) and 60% O2 during exercise at approximately 50% of their maximal incremental exercise capacity. Breathlessness ratings (Borg scale), endurance time, respiratory drive (change in mouth occlusion pressure over the first 0.1 s of inspiration, P0.1), ventilation (VE), breathing pattern, operational lung volumes, gas exchange, and metabolic parameters were compared during RA and 60% O2. PaO2 at exercise cessation during RA and 60% O2 was 65 +/- 3 mm Hg and 226 +/- 12 mm Hg, respectively (p < 0.001). With 60% O2, the mean of individual Borg/time slopes fell significantly (p < 0.05) by 23 +/- 12% and was associated with a 35 +/- 11% increase (p < 0.01) in endurance time (r = -0.64, p < 0.05). During 60% O2, slopes of P0.1 and lactate over time also fell significantly (p < 0.05), whereas delta PaCO2/time did not change significantly. At a standardized time near end-exercise, Borg, VE, and P0.1 changed during 60% O2 by -0.8 +/- 0.3 (p < 0.05), -4.1 +/- 2.0 L/min (p = 0.07), and - 1.3 +/- 0.5 cm H2O/s (p < 0.05), respectively. Slopes of Borg/VE, Borg/lactate, and VE/lactate were essentially superimposable during tests on RA and O2: Borg, lactate, and VE all fell proportionally during hyperoxia. In patients with CAL and mild exercise hypoxemia, relief of exertional breathlessness during hyperoxia is explained by reduced ventilatory demand in association with reduced blood lactate levels.

This article has been cited by other articles:

				P. Albert and P. M. A. Calverley Drugs (including oxygen) in severe COPD Eur. Respir. J., May 1, 2008; 31(5): 1114 - 1124. [Abstract] [Full Text] [PDF]

				D. E. O'Donnell, R. B. Banzett, V. Carrieri-Kohlman, R. Casaburi, P. W. Davenport, S. C. Gandevia, A. F. Gelb, D. A. Mahler, and K. A. Webb Pathophysiology of Dyspnea in Chronic Obstructive Pulmonary Disease: A Roundtable Proceedings of the ATS, May 1, 2007; 4(2): 145 - 168. [Abstract] [Full Text] [PDF]

				D. A. Mahler, L. A. Waterman, J. Ward, and J. C. Baird Responsiveness of Patient-Reported Breathlessness During Exercise in Persistent Asthma Chest, January 1, 2007; 131(1): 195 - 200. [Abstract] [Full Text] [PDF]

				J. M. Bradley, T. Lasserson, S. Elborn, J. MacMahon, and B. O'Neill A Systematic Review of Randomized Controlled Trials Examining the Short-term Benefit of Ambulatory Oxygen in COPD Chest, January 1, 2007; 131(1): 278 - 285. [Abstract] [Full Text] [PDF]

				P. M. A. Calverley Exercise and dyspnoea in COPD Eur. Respir. Rev., December 1, 2006; 15(100): 72 - 79. [Abstract] [Full Text] [PDF]

				E. F. M. Wouters Nonpharmacological modulation of dynamic hyperinflation Eur. Respir. Rev., December 1, 2006; 15(100): 90 - 96. [Abstract] [Full Text] [PDF]

				N. D. Eves, S. R. Petersen, M. J. Haykowsky, E. Y. Wong, and R. L. Jones Helium-Hyperoxia, Exercise, and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., October 1, 2006; 174(7): 763 - 771. [Abstract] [Full Text] [PDF]

				M M Peters, K A Webb, and D E O'Donnell Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD Thorax, July 1, 2006; 61(7): 559 - 567. [Abstract] [Full Text] [PDF]

				P. M. A. Calverley Dynamic Hyperinflation: Is It Worth Measuring? Proceedings of the ATS, May 1, 2006; 3(3): 239 - 244. [Abstract] [Full Text] [PDF]

				D. E. O'Donnell Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. Proceedings of the ATS, January 1, 2006; 3(2): 180 - 184. [Abstract] [Full Text] [PDF]

				R. Casaburi and J. Porszasz Reduction of hyperinflation by pharmacologic and other interventions. Proceedings of the ATS, January 1, 2006; 3(2): 185 - 189. [Abstract] [Full Text] [PDF]

				E. F. McKone, S. C. Barry, M. X. FitzGerald, and C. G. Gallagher Role of arterial hypoxemia and pulmonary mechanics in exercise limitation in adults with cystic fibrosis J Appl Physiol, September 1, 2005; 99(3): 1012 - 1018. [Abstract] [Full Text] [PDF]

				T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 19 - 38. [Full Text] [PDF]

				N. Ambrosino and S. Strambi New strategies to improve exercise tolerance in chronic obstructive pulmonary disease Eur. Respir. J., August 1, 2004; 24(2): 313 - 322. [Abstract] [Full Text] [PDF]

				N J Stevenson and P M A Calverley Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease Thorax, August 1, 2004; 59(8): 668 - 672. [Abstract] [Full Text] [PDF]

				N Ambrosino, D Giannini, and I D'Amico How good is the evidence for ambulatory oxygen in chronic obstructive pulmonary disease Chronic Respiratory Disease, July 1, 2004; 1(3): 125 - 126. [PDF]

				D.E. O'Donnell, T. Fluge, F. Gerken, A. Hamilton, K. Webb, B. Aguilaniu, B. Make, and H. Magnussen Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD Eur. Respir. J., June 1, 2004; 23(6): 832 - 840. [Abstract] [Full Text] [PDF]

				J A Wedzicha Short burst oxygen therapy is helpful? Chronic Respiratory Disease, April 1, 2004; 1(2): 101 - 103. [PDF]

				M. Emtner, J. Porszasz, M. Burns, A. Somfay, and R. Casaburi Benefits of Supplemental Oxygen in Exercise Training in Nonhypoxemic Chronic Obstructive Pulmonary Disease Patients Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1034 - 1042. [Abstract] [Full Text] [PDF]

				W MacNee and P M A Calverley Chronic obstructive pulmonary disease * 7: Management of COPD Thorax, March 1, 2003; 58(3): 261 - 265. [Abstract] [Full Text] [PDF]

				G. L. Snider Enhancement of Exercise Performance in COPD Patients by Hyperoxia: A Call for Research Chest, November 1, 2002; 122(5): 1830 - 1836. [Abstract] [Full Text] [PDF]

				D. E. O'Donnell, C. D'Arsigny, M. Fitzpatrick, and K. A. Webb Exercise Hypercapnia in Advanced Chronic Obstructive Pulmonary Disease: The Role of Lung Hyperinflation Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 663 - 668. [Abstract] [Full Text] [PDF]

				T. Eaton, J.E. Garrett, P. Young, W. Fergusson, J. Kolbe, S. Rudkin, and K. Whyte Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study Eur. Respir. J., August 1, 2002; 20(2): 306 - 312. [Abstract] [Full Text] [PDF]

				K. Fujimoto, Y. Matsuzawa, S. Yamaguchi, T. Koizumi, and K. Kubo Benefits of Oxygen on Exercise Performance and Pulmonary Hemodynamics in Patients With COPD With Mild Hypoxemia* Chest, August 1, 2002; 122(2): 457 - 463. [Abstract] [Full Text] [PDF]

				J Hadcroft and P M A Calverley Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease Thorax, September 1, 2001; 56(9): 713 - 720. [Abstract] [Full Text] [PDF]

				A. Somfay, J. Porszasz, S.M. Lee, and R. Casaburi Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients Eur. Respir. J., July 1, 2001; 18(1): 77 - 84. [Abstract] [Full Text] [PDF]

				D. E. O'DONNELL, C. D'ARSIGNY, and K. A. WEBB Effects of Hyperoxia on Ventilatory Limitation During Exercise in Advanced Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 892 - 898. [Abstract] [Full Text]

				J. M. Luce and J. A. Luce Management of Dyspnea in Patients With Far-Advanced Lung Disease: "Once I Lose It, It's Kind of Hard to Catch It . . . " JAMA, March 14, 2001; 285(10): 1331 - 1337. [Abstract] [Full Text] [PDF]

				M C Steiner and M D L Morgan Enhancing physical performance in chronic obstructive pulmonary disease Thorax, January 1, 2001; 56(1): 73 - 77. [Full Text]

				G. H. Guyatt, D. A. McKim, P. Austin, R. Bryan, J. Norgren, B. Weaver, and R. S. Goldstein Appropriateness of Domiciliary Oxygen Delivery Chest, November 1, 2000; 118(5): 1303 - 1308. [Abstract] [Full Text] [PDF]

				P. Weiner, R. Magadle, N. Berar-Yanay, A. Davidovich, and M. Weiner The Cumulative Effect of Long-Acting Bronchodilators, Exercise, and Inspiratory Muscle Training on the Perception of Dyspnea in Patients With Advanced COPD Chest, September 1, 2000; 118(3): 672 - 678. [Abstract] [Full Text] [PDF]

				P M A CALVERLEY Supplementary oxygen therapy in COPD: is it really useful? Thorax, July 1, 2000; 55(7): 537 - 538. [Full Text]

				R Garrod, E A Paul, and J A Wedzicha Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia Thorax, July 1, 2000; 55(7): 539 - 543. [Abstract] [Full Text]

				H. R Gosker, E. F. Wouters, G. J van der Vusse, and A. M. Schols Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1033 - 1047. [Abstract] [Full Text] [PDF]

				D. E. O'DONNELL, M. LAM, and K. A. WEBB Spirometric Correlates of Improvement in Exercise Performance after Anticholinergic Therapy in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 542 - 549. [Abstract] [Full Text]

				P. Meek Dyspnea . Mechanisms, Assessment, and Management: A Consensus Statement Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 321 - 340. [Full Text]

				D. E. O'DONNELL, M. LAM, and K. A. WEBB Measurement of Symptoms, Lung Hyperinflation, and Endurance during Exercise in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 1998; 158(5): 1557 - 1565. [Abstract] [Full Text] [PDF]